- Home
- GPCR vs FINV Comparison
GPCR vs FINV Comparison
Compare GPCR & FINV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPCR
- FINV
- Stock Information
- Founded
- GPCR 2016
- FINV 2007
- Country
- GPCR United States
- FINV China
- Employees
- GPCR N/A
- FINV N/A
- Industry
- GPCR
- FINV Finance: Consumer Services
- Sector
- GPCR
- FINV Finance
- Exchange
- GPCR Nasdaq
- FINV Nasdaq
- Market Cap
- GPCR 1.8B
- FINV 1.5B
- IPO Year
- GPCR 2023
- FINV N/A
- Fundamental
- Price
- GPCR $40.36
- FINV $5.33
- Analyst Decision
- GPCR Buy
- FINV
- Analyst Count
- GPCR 6
- FINV 0
- Target Price
- GPCR $81.33
- FINV N/A
- AVG Volume (30 Days)
- GPCR 593.8K
- FINV 546.6K
- Earning Date
- GPCR 08-08-2024
- FINV 08-20-2024
- Dividend Yield
- GPCR N/A
- FINV 4.47%
- EPS Growth
- GPCR N/A
- FINV N/A
- EPS
- GPCR N/A
- FINV 1.11
- Revenue
- GPCR N/A
- FINV $1,762,418,497.00
- Revenue This Year
- GPCR N/A
- FINV $7.13
- Revenue Next Year
- GPCR N/A
- FINV $8.36
- P/E Ratio
- GPCR N/A
- FINV $4.79
- Revenue Growth
- GPCR N/A
- FINV 4.17
- 52 Week Low
- GPCR $26.61
- FINV $4.22
- 52 Week High
- GPCR $75.02
- FINV $5.80
- Technical
- Relative Strength Index (RSI)
- GPCR 57.92
- FINV 52.23
- Support Level
- GPCR $38.27
- FINV $5.19
- Resistance Level
- GPCR $42.67
- FINV $5.30
- Average True Range (ATR)
- GPCR 2.29
- FINV 0.10
- MACD
- GPCR 0.31
- FINV -0.01
- Stochastic Oscillator
- GPCR 76.72
- FINV 82.00
About GPCR Structure Therapeutics Inc.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company aiming to develop and deliver novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, a validated G-protein-coupled receptors (GPCRs) drug target for type-2 diabetes mellitus and obesity. The company is also developing oral small-molecule therapeutics targeting other GPCRs for the treatment of pulmonary and cardiovascular diseases, including ANPA-0073 and LTSE-2578.
About FINV FinVolution Group
FinVolution Group is a provider of online consumer finance in China. It offers various loan products, making financial services available to borrowers anytime, anywhere; designs a loan transaction process, and offers Tailored risk-based pricing. It offers short-term loans to borrowers to meet immediate credit needs while allowing them to gradually establish their credit history through activities on the company's platform. The company provides investors with an opportunity to invest in emerging asset class-consumer loans through a variety of investment options. It generates revenues from fees charged to borrowers. The Group's long-lived assets are located in the PRC and its revenues are derived from within the PRC.